Product
TDF Placebo
2 clinical trials
1 indication
Indication
Chronic Hepatitis BClinical trial
A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Patients With Chronic Hepatitis B InfectionStatus: Active (not recruiting), Estimated PCD: 2017-08-07
Clinical trial
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD Versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Positive, Chronic Hepatitis BStatus: Completed, Estimated PCD: 2015-11-16